Clinical analysis of MOG
antibody-associated disease overlapped with anti-NMDA receptor
encephalitis: a long-term retrospective
study
Tianjiao Duan1,2, Song Ouyang3,4,
Zhaolan Hu5, Qiuming Zeng6, Weifan
Yin1,2,4*
1
Department
of Neurology, the Second Xiangya Hospital, Central South University,
Changsha, Hunan, P.R. China
2 Clinical Medical Research Center
for Stroke Prevention and Treatment of Hunan Province, Department of
Neurology, the Second Xiangya Hospital, Central South University,
Changsha, Hunan, P.R. China
3 Department of Neurology, the affiliated Changsha Hospital of Xiangya
School of Medicine, Central South University, Changsha, Hunan, P.R.
China
4 The “Double-First Class” Application Characteristic Discipline of
Hunan Province (Clinical Medicine), Changsha Medical University,
Changsha, Hunan, P.R. China
5 Department of Anesthesiology, the
Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R.
China
6 Department of Neurology, Xiangya Hospital, Central South University,
Changsha, Hunan, P.R. China
* Correspondence to:
Weifan Yin, M.D., Ph.D.
Department of Neurology, The Second Xiangya Hospital, Central South
University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, P.R.
China
Email: yinweifan1985@csu.edu.cn
Keyword: myelin oligodendrocyte glycoprotein (MOG), MOG
antibody–associated disease, NMDAR encephalitis, MOG antibodies and
anti-NMDAR encephalitis overlapping syndrome.